波音游戏-波音娱乐城赌球打不开

Mapping a biotech future in Hong Kong

Regina Lau

 

Recent biotech achievements in China offer immense opportunities for Hong Kong to enhance her position in biotechnology, one of the most promising industries for coming decades, said Professor Y L Lo, Founding Chairman of the Hong Kong Biotechnology Association, at CityU on 20 January. Professor Lo's lecture, "Biotechnology-the Catalyst of Hong Kong's Future Economic Development?" was the latest in the Distinguished Industrialist Lecture Series, organized by CityU's Faculty of Science and Engineering to foster closer links between the University community and the business sector. "Collaborating with China and participation in i

nternational biotech projects are crucial steps for Hong Kong to establish itself in this mega trend for the 21st century," he told the audience.

Professor Lo, who is also the President (Asia Pacific) of PerkinElmer Life and Sciences (Hong Kong) Limited, a US based biotech company, gave a comprehensive picture of biotech development in the Asia Pacific region, which is set to become the engine for global economic growth. Governments in Taiwan, Korea, Singapore and Japan have shown a clear commitment to expanding the biotech industry, which has also experienced booming investment from the private sector. With her growing contributions to the Human Genome Project, breakthroughs in decoding the hybrid rice genome, and production of recombinant drugs and vaccines, China is capable of becoming a future leader in the Asia biotech industry, he said.

"In Hong Kong, the biotech industry is currently very much trade-based. We are lagging behind our neighbors in terms of technological innovation and R&D investment," said Professor Lo. "But with a strong service base, heightened awareness among our entrepreneurs of the huge potential of the life science industry, and our position as China's bridge to the world, Hong Kong is well situated to find a niche in the booming biotech field."

The process of commercialization and technology transfer in biotechnology creates huge opportunities for various sectors, including the legal and fina

nce sectors. Instead of starting from scratch, Hong Kong should focus on the advanced stages of the process, Professor Lo said. "Immense opportunities in servicing and intellectual property protection at the advanced stage of the process are waiting to be explored." 

 

你可能感興趣

聯絡資料

傳訊及數據研究處

Back to top
大发888信誉最新娱乐| 百家乐趋势方向| 南京百家乐官网赌博现场被 | 百家乐补第三张牌规则| 日土县| 百家乐技巧发布| 香港六合彩马报| 查找百家乐官网群| 大发888boaicai| 百家乐官网试玩1000元| 澳门百家乐博| 权威百家乐官网信誉网站| 百家乐娱乐城体验金| 百家乐官网游乐园| 太阳城申博| 百家乐官网娱乐分析软件v4.0| 赌球术语| 百家乐官网网络赌城| 菲律宾百家乐太阳城| 百家乐百胜注码法| 百家乐官网开户就送现金| 百家乐赌博技巧网| 真人百家乐官网网站接口| 伯爵百家乐赌场娱乐网规则 | 玩百家乐官网的玩法技巧和规则 | 大发888下载英皇国际| 雅加达百家乐官网的玩法技巧和规则 | 最好的百家乐官网博彩公司| 百家乐德州扑克桌布| 百家乐官网真人游戏娱乐场| 大发888注册送钱| 总格24画的名字好吗| 日博娱乐城| 百家乐必赢法软件| 赌博游戏平台| 永利百家乐娱乐网| 澳门百家乐官网才能| 大发888bet亚洲lm0| 百家乐筛子游戏| 独赢百家乐官网全讯网| 威尼斯人娱乐场有什么玩|